H. pylori in stomach cancers in the French West Indies
Prevalence of H. Pylori in Stomach Cancers in the West Indies
This project will test how common H. pylori infection is in adults newly diagnosed with stomach cancer in Guadeloupe.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de la Guadeloupe Academic / other |
| Locations | 2 sites (Baie-Mahault and 1 other locations) |
| Trial ID | NCT07233447 on ClinicalTrials.gov |
What this trial studies
This observational study will use immunohistochemistry on tumor tissue to detect H. pylori in patients with a new diagnosis of gastric cancer. Participants are adults living in Guadeloupe who provide informed consent and have social security coverage. The goal is to estimate the prevalence of H. pylori in these cancers to improve regional epidemiologic knowledge. Results will help contextualize local risk factors such as diet and possible environmental exposures that may contribute to excess incidence.
Who should consider this trial
Good fit: Adults over 18 who have a new primary diagnosis of gastric cancer, have lived in Guadeloupe for more than six months, can give consent, and are covered by social security.
Not a fit: People who cannot consent, lack social security coverage, are under legal protection, are pregnant or breastfeeding, or are not residents of Guadeloupe are not eligible and would not benefit from participation.
Why it matters
Potential benefit: If successful, the study could clarify how often H. pylori is present in gastric cancers in Guadeloupe and inform local prevention and treatment strategies.
How similar studies have performed: Many prior studies worldwide have linked H. pylori to stomach cancer and used immunohistochemistry to detect the bacterium, but prevalence data specific to the French West Indies are limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient over 18 years of age residing in Guadeloupe for more than 6 months and with a primary diagnosis of gastric cancer * Patient having read the information note and having signed the consent to participate in the study * Patient with social security coverage. Exclusion Criteria: * Refusal to participate. * Patient who could not answer the questionnaires * Patient not affiliated to a social security scheme * Patient under legal protection (judicial safeguard, guardianship, curatorship, etc.) * Pregnant or breastfeeding woman * Subject participating in another research study that includes an exclusion period still ongoing at the time of pre-inclusion
Where this trial is running
Baie-Mahault and 1 other locations
- Cabinet Galeries de Houelbourg — Baie-Mahault, Guadeloupe (Recruiting)
- CHU de la Guadeloupe — Pointe-à-Pitre, Guadeloupe (Recruiting)
Study contacts
- Study coordinator: Mélanie petapermal, Master degree
- Email: melanie.petapermal@chu-guadeloupe.fr
- Phone: +590590934667
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.